SEC Form 4 · accession 0001203311-18-000024
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Darren S Cline
Officer — EVP, Commercial
Period of report
May 3, 2018
Accepted (ET)
May 7, 2018 · 7:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 3, 2018 | S | 4,000 | $53.8096 | D | 71,831 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reflects sales of Common Stock executed in multiple transactions at prices ranging from $53.78 to $53.85. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission Staff, the Issuer or a Security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- F2Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.